Editorial Volume 4, Issue 10 pp 660—661

Rapamycin as longevity enhancer and cancer preventative agent in the context of p53 deficiency

Lawrence A. Donehower1, ,

  • 1 Departments of Molecular Virology & Microbiology, Molecular & Cellular Biology, and Pediatrics, Baylor College of Medicine, Houston, TX 77030

Received: October 25, 2012       Published: October 27, 2012      

https://doi.org/10.18632/aging.100494
How to Cite
Download PDF